EPM speaks to a range of pharma players to find out how Covid-19 is affecting the various aspects of the pharmaceutical supply chain.
Covid-19
The latest strain of coronavirus – Covid-19 – has shook the world, giving countries, their health systems and indeed patients something to seriously consider. Alongside its human impact and the economic downfall caused by its spread, Covid-19 is affecting a large majority of the pharmaceutical supply chain.
Clinical Trials
With 35 candidate vaccines currently in pre-clinical development for Covid-19, the race is officially on to find a solution and prevent the virus from spreading even further. Of course, development timelines for vaccines are rarely short, and the pharma industry is facing an almost insurmountable task of developing a vaccine before Covid-19 burns itself out.